Rapid fluoroquinolone resistance detection in Pseudomonas aeruginosa using mismatch amplification mutation assay-based real-time PCR

References

1. Breidenstein EBM, de la Fuente-Núñez C, Hancock REW. Pseudomonas aeruginosa: all roads lead to resistance. Trends Microbiol 2011; 19:419–426 [View Article]
   [Google Scholar]
2. Botelho J, Grosso F, Peixe L. Antibiotic resistance in Pseudomonas aeruginosa - mechanisms, epidemiology and evolution. Drug Resist Updat 2019; 44:100640 [View Article]
   [Google Scholar]
3. Schwartz T, Volkmann H, Kirchen S, Kohnen W, Schön-Hölz K et al. Real-time PCR detection of Pseudomonas aeruginosa in clinical and municipal wastewater and genotyping of the ciprofloxacin-resistant isolates. FEMS Microbiol Ecol 2006; 57:158–167 [View Article]
   [Google Scholar]
4. Higgins PG, Fluit AC, Milatovic D, Verhoef J, Schmitz FJ. Mutations in GyrA, ParC, MexR and NfxB in clinical isolates of Pseudomonas aeruginosa. Int J Antimicrob Agents 2003; 21:409–413 [View Article]
   [Google Scholar]
5. Poole K. Pseudomonas aeruginosa: resistance to the max. Front Microbiol 2011; 2:65 [View Article]
   [Google Scholar]
6. Lee JK, Lee YS, Park YK, Kim BS. Alterations in the GyrA and GyrB subunits of topoisomerase II and the ParC and ParE subunits of topoisomerase IV in ciprofloxacin-resistant clinical isolates of Pseudomonas aeruginosa. Int J Antimicrob Agents 2005; 25:290–295 [View Article]
   [Google Scholar]
7. Yonezawa M, Takahata M, Matsubara N, Watanabe Y, Narita H. DNA gyrase gyrA mutations in quinolone-resistant clinical isolates of Pseudomonas aeruginosa. Antimicrob Agents Chemother 1995; 39:1970–1972 [View Article]
   [Google Scholar]
8. Rehman A, Jeukens J, Levesque RC, Lamont IL. Gene-gene interactions dictate ciprofloxacin resistance in Pseudomonas aeruginosa and facilitate prediction of resistance phenotype from genome sequence data. Antimicrob Agents Chemother 2021; 65:e0269620 [View Article]
   [Google Scholar]
9. Micek ST, Lloyd AE, Ritchie DJ, Reichley RM, Fraser VJ et al. Pseudomonas aeruginosa bloodstream infection: importance of appropriate initial antimicrobial treatment. Antimicrob Agents Chemother 2005; 49:1306–1311 [View Article]
   [Google Scholar]
10. Darie AM, Khanna N, Jahn K, Osthoff M, Bassetti S et al. Fast multiplex bacterial PCR of bronchoalveolar lavage for antibiotic stewardship in hospitalised patients with pneumonia at risk of Gram-negative bacterial infection (Flagship II): a multicentre, randomised controlled trial. Lancet Respir Med 2022S2213-2600(22)00086-8 [View Article]
    [Google Scholar]
11. Nguyen KV, Nguyen TV, Nguyen HTT, Le DV. Mutations in the gyrA, parC, and mexR genes provide functional insights into the fluoroquinolone-resistant Pseudomonas aeruginosa isolated in Vietnam. Infect Drug Resist 2018; 11:275–282 [View Article]
    [Google Scholar]
12. Rehman A, Patrick WM, Lamont IL. Mechanisms of ciprofloxacin resistance in Pseudomonas aeruginosa: new approaches to an old problem. J Med Microbiol 2019; 68:1–10 [View Article]
    [Google Scholar]
13. Kos VN, Déraspe M, McLaughlin RE, Whiteaker JD, Roy PH et al. The resistome of Pseudomonas aeruginosa in relationship to phenotypic susceptibility. Antimicrob Agents Chemother 2015; 59:427–436 [View Article]
    [Google Scholar]
14. Birdsell DN, Pearson T, Price EP, Hornstra HM, Nera RD et al. Melt analysis of mismatch amplification mutation assays (Melt-MAMA): a functional study of a cost-effective SNP genotyping assay in bacterial models. PLoS One 2012; 7:e32866 [View Article]
    [Google Scholar]
15. Germer S, Higuchi R. Single-tube genotyping without oligonucleotide probes. Genome Res 1999; 9:72–78 [View Article]
    [Google Scholar]
16. Donà V, Smid JH, Kasraian S, Egli-Gany D, Dost F et al. Mismatch amplification mutation assay-based real-time PCR for rapid detection of Neisseria gonorrhoeae and antimicrobial resistance determinants in clinical specimens. J Clin Microbiol 2018; 56:e00365–00318 [View Article]
    [Google Scholar]
17. Sarovich DS, Price EP, Von Schulze AT, Cook JM, Mayo M et al. Characterization of ceftazidime resistance mechanisms in clinical isolates of Burkholderia pseudomallei from Australia. PLoS One 2012; 7:e30789 [View Article]
    [Google Scholar]
18. Germer S, Holland MJ, Higuchi R. High-throughput SNP allele-frequency determination in pooled DNA samples by kinetic PCR. Genome Res 2000; 10:258–266 [View Article]
    [Google Scholar]
19. Webb KA, Olagoke O, Baird T, Neill J, Pham A et al. Genomic diversity and antimicrobial resistance of Prevotella species isolated from chronic lung disease airways. Microb Genom 2022; 8:000754 [View Article]
    [Google Scholar]
20. McCarthy KL, Paterson DL. Long-term mortality following Pseudomonas aeruginosa bloodstream infection. J Hosp Infect 2017; 95:292–299 [View Article]
    [Google Scholar]
21. Freschi L, Jeukens J, Kukavica-Ibrulj I, Boyle B, Dupont M-J et al. Clinical utilization of genomics data produced by the international Pseudomonas aeruginosa consortium. Front Microbiol 2015; 6:1036 [View Article]
    [Google Scholar]
22. Anuj SN, Whiley DM, Kidd TJ, Bell SC, Wainwright CE et al. Identification of Pseudomonas aeruginosa by a duplex real-time polymerase chain reaction assay targeting the ecfX and the gyrB genes. Diagn Microbiol Infect Dis 2009; 63:127–131 [View Article]
    [Google Scholar]
23. Stewart AG, Price EP, Schabacker K, Birikmen M, Harris PNA et al. Molecular epidemiology of third-generation-cephalosporin-resistant Enterobacteriaceae in southeast Queensland, Australia. Antimicrob Agents Chemother 2021; 65:e00130–21 [View Article]
    [Google Scholar]
24. Price EP, Viberg LT, Kidd TJ, Currie BJ et al. Transcriptomic analysis of longitudinal Burkholderia pseudomallei infecting the cystic fibrosis lung. Microb Genom 2018; 4:e000194 [View Article]
    [Google Scholar]
25. Bankevich A, Nurk S, Antipov D, Gurevich AA, Dvorkin M et al. SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing. J Comput Biol 2012; 19:455–477 [View Article]
    [Google Scholar]
26. Madden DE, Baird T, Bell SC, McCarthy KL. Keeping up with the pathogens: Improved antimicrobial resistance detection and prediction in Pseudomonas aeruginosa. MedRxiv 2022 [View Article]
    [Google Scholar]
27. Madden DE, Webb JR, Steinig EJ, Currie BJ, Price EP et al. Taking the next-gen step: Comprehensive antimicrobial resistance detection from Burkholderia pseudomallei. EBioMedicine 2021; 63:103152 [View Article]
    [Google Scholar]
28. de Lamballerie X, Zandotti C, Vignoli C, Bollet C, de Micco P. A one-step microbial DNA extraction method using “Chelex 100” suitable for gene amplification. Res Microbiol 1992; 143:785–790 [View Article]
    [Google Scholar]
29. van Belkum A, Soriaga LB, LaFave MC, Akella S, Veyrieras J-B et al. Phylogenetic distribution of CRISPR-cas systems in antibiotic-resistant Pseudomonas aeruginosa. mBio 2015; 6:e01796–15 [View Article]
    [Google Scholar]
30. Cabot G, López-Causapé C, Ocampo-Sosa AA, Sommer LM, Domínguez MÁ et al. Deciphering the resistome of the widespread Pseudomonas aeruginosa sequence type 175 international high-risk clone through whole-genome sequencing. Antimicrob Agents Chemother 2016; 60:7415–7423 [View Article]
    [Google Scholar]
31. Del Barrio-Tofiño E, López-Causapé C, Cabot G, Rivera A, Benito N et al. Genomics and susceptibility profiles of extensively drug-resistant Pseudomonas aeruginosa isolates from Spain. Antimicrob Agents Chemother 2017; 61:1–13 [View Article]
    [Google Scholar]
32. Sherrard LJ, Tai AS, Wee BA, Ramsay KA, Kidd TJ et al. Within-host whole genome analysis of an antibiotic resistant Pseudomonas aeruginosa strain sub-type in cystic fibrosis. PLoS One 2017; 12:1–15 [View Article]
    [Google Scholar]
33. Fraser TA, Bell MG, Harris PNA, Bell SC, Bergh H et al. Quantitative real-time PCR assay for the rapid identification of the intrinsically multidrug-resistant bacterial pathogen Stenotrophomonas maltophilia. Microb Genom 2019; 5:e000307 [View Article]
    [Google Scholar]
34. Tsang KK, Maguire F, Zubyk HL, Chou S, Edalatmand A et al. Identifying novel β-lactamase substrate activity through in silico prediction of antimicrobial resistance. Microb Genom 2021; 7:000500 [View Article]
    [Google Scholar]
35. Buhl M, Kästle C, Geyer A, Autenrieth IB, Peter S et al. Molecular evolution of extensively drug-resistant (XDR) Pseudomonas aeruginosa strains from patients and hospital environment in a prolonged outbreak. Front Microbiol 2019; 10:1742 [View Article]
    [Google Scholar]
36. Ramanathan B, Jindal HM, Le CF, Gudimella R, Anwar A et al. Next generation sequencing reveals the antibiotic resistant variants in the genome of Pseudomonas aeruginosa. PLoS One 2017; 12:e0182524 [View Article]
    [Google Scholar]
37. Farahi RM, Ali AA, Gharavi S. Characterization of gyra and parc mutations in ciprofloxacin-resistant Pseudomonas aeruginosa isolates from tehran hospitals in iran. Iran J Microbiol 2018; 10:242–249
    [Google Scholar]
38. Takenouchi T, Sakagawa E, Sugawara M. Detection of gyrA mutations among 335 Pseudomonas aeruginosa strains isolated in Japan and their susceptibilities to fluoroquinolones. Antimicrob Agents Chemother 1999; 43:406–409 [View Article]
    [Google Scholar]
39. Akasaka T, Tanaka M, Yamaguchi A, Sato K. Type II topoisomerase mutations in fluoroquinolone-resistant clinical strains of Pseudomonas aeruginosa isolated in 1998 and 1999: role of target enzyme in mechanism of fluoroquinolone resistance. Antimicrob Agents Chemother 2001; 45:2263–2268 [View Article]
    [Google Scholar]
40. Kidd TJ, Ritchie SR, Ramsay KA, Grimwood K, Bell SC et al. Pseudomonas aeruginosa exhibits frequent recombination, but only a limited association between genotype and ecological setting. PLoS One 2012; 7:e44199 [View Article]
    [Google Scholar]
41. Bergkessel M, Guthrie C. Colony PCR. Methods Enzymol 2013; 529:299–309 [View Article]
    [Google Scholar]
42. Levin BR, Perrot V, Walker N. Compensatory mutations, antibiotic resistance and the population genetics of adaptive evolution in bacteria. Genetics 2000; 154:985–997 [View Article]
    [Google Scholar]